logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

James M. Foran

mayo clinic phoenix
H指数:51
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s)

克隆性单核细胞增多症的临床和分子特征：伴有与不伴有血细胞减少（症）的比较

Leukemia
IF13.4
2026-09-280
PRE
Tariq Kewan; Hadil Zureigat; Pradeep Pankaj; Rong He; Dragan Jevremovic; Patricia Greipp; Antoine N. Saliba; Aasiya Matin; Mehrdad Hefazi Torghabeh; Naseema Gangat; William Hogan; Hassan Alkhateeb; Cecilia Arana Yi; James Foran; Mark Litzow; Mithun Vinod Shah; Kebede Begna; Badar Talha; Yael Kusne; Abhishek A. Mangaonkar; Aref Al-Kali; Kaaren Reichard; Mrinal M. Patnaik
Venetoclax Plus Hypomethylating Agent for 7- Versus 14- Versus 21- Versus 28-Day Cycles in Newly-Diagnosed Acute Myeloid Leukemia: ELN and Mayo Genetic Risk–Stratified Analysis in 540 Patients

维奈克拉联合去甲基化药物用于新诊断急性髓系白血病7天、14天、21天及28天疗程：基于ELN和Mayo遗传风险分层的540例患者分析

American Journal of Hematology
IF9.9
2026-09-180
PRE
Sudhesh Kumar; Momna Warraich; Mahnoor Fatima; Kristen McCullough; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek A. Mangaonkar; Antoine N. Saliba; Mark R. Litzow; William Hogan; Mithun Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; James Foran; Jeanne Palmer; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat
Coronary Artery Calcification as a Predictor of Survival in Patients Receiving Post-transplant Cyclophosphamide for GVHD Prophylaxis

冠状动脉钙化作为接受移植后环磷酰胺预防GVHD患者的生存预测因子

Transplantation and Cellular Therapy
IF4.4
2026-09-012
OAAI
Graham, Christopher; Baranwal, Anmol; Kietselaer, Bas; Ayoub, Chadi; Larsen, Carolyn; Langer, Kimberly J.; Kharfan-Dabaja, Mohamed A.; Ayala, Ernesto; Foran, James; Murthy, Hemant; Roy, Vivek; Iqbal, Madiha; Palmer, Jeanne; Sproat, Lisa Z.; Chhabra, Saurabh; Khera, Nandita; Hilal, Talal; Durani, Urshila; Matin, Aasiya; Torghabeh, Mehrdad Hefazi; Mangaonkar, Abhishek; Shah, Mithun, V; Litzow, Mark R.; Hogan, William J.; Dingli, David; Alkhateeb, Hassan B.
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study
Leukemia
IF13.4
2026-08-310
PRE
Talha Badar; James Foran; Omer Jamy; Chenyu Lin; Anand Patel; Yu-Hung Wang; Mahesh Kumar; Rory M. Shallis; Kendall Diebold; Alexander Coltoff; Aaron D. Goldberg; Jan P. Bewersdorf; Kenneth M. Zabel; Charles Foucar; Yasmin Abaza; Guru S. Murthy; Neil Palmisiano; Adam S. DuVall; Vamsi Kota; Shyam A. Patel; Amer M. Zeidan; Hemant Murthy; Mohamed Kharfan-Dabaja; Ehab Atallah; Mark R. Litzow
Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia

356例新诊断急性髓系白血病患者一线维奈克拉联合去甲基化药物治疗失败后的生存影响因素

Blood Cancer Journal
IF11.6
2026-08-170
OAAI
Mahnoor Fatima; Sudhesh Kumar; Momna Warraich; Kristen McCullough; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek Mangaonkar; Antoine N. Saliba; Mark R. Litzow; William Hogan; Mithun V. Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; James Foran; Jeanne Palmer; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients

慢性髓系单核细胞白血病患者行异基因干细胞移植与未移植者的风险调整生存比较：梅奥诊所775例连续患者的经验

American Journal of Hematology
IF9.9
2026-07-280
PRE
Ali Alsugair; Saubia Fathima; Mohammad M. Alhousani; Estefania Gauto Mariotti; Abiola Bolarinwa; Priyansh Faldu; Muhammad Yousuf; Clifford M. Csizmar; James Foran; Abishek A. Mangaonkar; Mark Litzow; Hemant Murthy; Lisa Sproat; Jeanne Palmer; Aasiya Matin; Ernesto Ayala; James Slack; Luis Porrata; Madiha Iqbal; Nandita Khera; Nathan Punwani; Saad Kenderian; Saurabh Chhabra; Kebede H. Begna; Animesh Pardanani; William J. Hogan; Mithun Vinod Shah; Hassan B. Alkhateeb; Naseema Gangat; Mrinal Patnaik; Ayalew Tefferi
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients

CPX-351（脂质体阿糖胞苷和柔红霉素）与维奈克拉联合表观遗传药物疗法在初诊急性髓系白血病中的比较：一项涉及600例梅奥诊所患者的回顾性比较研究

Blood Cancer Journal
IF11.6
2026-04-060
OAAI
Saubia Fathima; Lior Rokach; Nour Ghosoun; Mahsa Rezasoltani; Rimal Ilyas; Ali Alsugair; Kristen McCullough; Maymona Abdelmagid; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek A. Mangaonkar; Aasiya Matin; Antoine N. Saliba; Mehrdad Hefazi Torghabeh; Mark R. Litzow; William Hogan; Mithun Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; Hemant Murthy; James Foran; Jeanne Palmer; Nathan Punwani; Lisa Sproat; Nandita Khera; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat
Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex

骨髓增生异常综合征及前体状态在种族、族裔和性别方面的临床、遗传和病理学变异

American Journal of Hematology
IF9.9
2026-03-290
OAAI
Nancy Gillis; Christelle Colin-Leitzinger; Yi-Han Tang; Michael Otterstatter; Seth Sherman; Ling Zhang; Lynn C. Moscinski; Mary Ellen Walker; Jeffrey S. Painter; Gregory A. Abel; Tareq Al Baghdadi; H. Joachim Deeg; James M. Foran; Steven D. Gore; Alexandra M. Harrington; Steven H. Kroft; Jane Jijun Liu; Wael Saber; Shamsuddin Virani; Rafael Bejar; R. Coleman Lindsley; Eric Padron; Matthew J. Walter; Rami Komrojki; Amy E. DeZern; Mikkael A. Sekeres
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE)

初步安全性和有效性：Navitoclax联合Ruxolitinib在Janus Kinase抑制剂初治的骨髓纤维化患者中的研究（多中心、开放标签、II期研究REFINE）

Hematological Oncology
IF3.9
2026-03-170
OAAI
Francesco Passamonti; James M. Foran; Anand Tandra; Valerio De Stefano; Maria Laura Fox; Ahmad Mattour; Mary Frances McMullin; Andrew C. Perkins; Gabriela Rodriguez-Macías; Hassan A. Sibai; Akshanth R. Polepally; Yan Sun; Avijeet S. Chopra; Jason G. Harb; Qin Qin; Jalaja Potluri; Jonathan How
Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significance

克隆性细胞减少症未定意义患者风险评分模型的独特优势

British Journal of Haematology
IF3.8
2026-02-250
PRE
Yazan Jabban; Rong He; Kurt Bessonen; Patricia Greipp; Dragan Jevremovic; David S. Viswanatha; James M. Foran; Talha Badar; Cecilia Arana Yi; Yael N. Kusne; Antoine N. Saliba; Mehrdad Hefazi; Aasiya Matin; William J. Hogan; Abhishek A. Mangaonkar; Mithun Vinod Shah; Hassan B. Alkhateeb; Mrinal M. Patnaik; Aref Al-Kali
TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast-Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating Agent

TP53突变和循环 blasts ≥20% 是接受一线维奈克拉联合去甲基化药物治疗加速期/原始细胞期骨髓增殖性肿瘤患者生存的主要决定因素

American Journal of Hematology
IF9.9
2026-02-180
OAAI
Naseema Gangat; Momna Warraich; Sudhesh Kumar; Mahnoor Fatima; Kristen McCullough; Kebede H. Begna; Aref Al-Kali; Mrinal M. Patnaik; William J. Hogan; Abhishek Mangaonkar; Antoine N. Saliba; Mehrdad Hefazi Torghabeh; Hassan Alkhateeb; Mithun V. Shah; James M. Foran; Talha Badar; Jeanne M. Palmer; Cecilia Arana Yi; Animesh Pardanani; Ayalew Tefferi
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.

PPM1D基因突变的谱系、患病率及与克隆性造血和克隆性血细胞减少症患者的临床相关性。

Blood Advances
IF7.1
2026-01-090
OAAI
Talha Badar; Ludovica Marando; Eric Latorre; Terra Lasho; Francyess Denis Olivia; Chenyu Lin; Benjamin J. McCormick; Mobachir El Kettani; Kashish J. Shah; Yael Kusne; Omer Jamy; Kendall Diebold; Alexander Coltoff; Christy Finke; James Foran; Mohamed Kharfan-Dabaja; Yao-Shan Fan; Liuyan Jiang; Rong He; Miles Thomas
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment

新诊断急性髓系白血病未接受治疗患者的特征

Haematologica
IF7.9
2026-01-010
OA
Alkabbani, Oudai; Jabban, Yazan; He, Rong; Viswanatha, David; Bessonen, Kurt; Greipp, Patricia; Jevremovic, Dragan; Foran, James M.; Badar, Talha; Yi, Cecilia Arana; Kusne, Yael; Saliba, Antoine N.; Torghabeh, Mehrdad Hefazi; Matin, Aasiya; Hogan, William J.; Mangaonkar, Abhishek; Alkhateeb, Hassan; Patnaik, Mrinal; Shah, Mithun; Begna, Kebede; Litzow, Mark R.; Al-Kali, Aref
Clinical and Prognostic Impact of Allelic Status in EZH2-Mutated Myeloid Neoplasms

EZH2突变髓系肿瘤中等位基因状态的临床及预后影响

Hematological Oncology
IF3.9
2025-10-230
PRE
Muhamad Oum; Ahmad Nanaa; Yazan Jabban; David Viswanatha; Rong He; Dragan Jevremovic; James M. Foran; Talha Badar; Cecilia Arana Yi; Patricia T. Greipp; Aasiya Matin; Mehrdad Hefazi; William J. Hogan; Antoine N. Saliba; Mrinal Patnaik; Abhishek A. Mangaonkar; Mithun Shah; Hassan B. Alkhateeb; Aref Al-Kali
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients

异基因干细胞移植在慢性髓单核细胞白血病中的应用：对138例梅奥诊所患者移植后生存及危险因素的分析

Blood Cancer Journal
IF11.6
2025-10-060
OA
Ali Alsugair; Estefania Gauto Mariotti; Mohammad M. Alhousani; Saubia Fathima; Muhammad Yousuf; Abiola Bolarinwa; James Foran; Abishek A. Mangaonkar; Mark Litzow; Hemant Murthy; Lisa Sproat; Jeanne Palmer; Aasiya Matin; Ernesto Ayala; James Slack; Luis Porrata; Madiha Iqbal; Nandita Khera; Nathan Punwani; Saad Kenderian; Saurabh Chhabra; William J. Hogan; Mithun Vinod Shah; Hassan B. Alkhateeb; Naseema Gangat; Mrinal Patnaik; Ayalew Tefferi
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia

异基因细胞移植治疗慢性髓性白血病患者的临床结局

LEUKEMIA & LYMPHOMA
IF2.2
2025-10-010
PRE
McCormick, Benjamin; Findley, Anthony; Diebold, Kendall; Bourne, Garrett; Hardee, Maris; Foran, James; Kharfan-Dabaja, Mohamed; Murthy, Hemant; Iqbal, Madiha; Gangat, Naseema; Sproat, Lisa; Palmer, Jeanne; Hogan, William J.; Begna, Kebede; Litzow, Mark; Tefferi, Ayalew; Patnaik, Mrinal; Bhatia, Ravi; Jamy, Omer; Badar, Talha
Applicability of current prognostication models for MDS patients with DDX41 mutation

DDX41突变伴发MDS患者现有预后模型的适用性

LEUKEMIA RESEARCH
IF2.2
2025-10-010
PRE
Toumeh, Nadia; Jabban, Yazan; He, Rong; Viswanatha, David; Jevremovic, Dragan; Greipp, Patricia T.; Foran, James M.; Badar, Talha; Yi, Cecilia Y. Arana; Kusne, Yael; Saliba, Antoine N.; Thorghabeh, Mehrdad Hefazi; Matin, Aasiya; Hogan, William J.; Shah, Mithun, V; Mangaonkar, Abhishek A.; Patnaik, Mrinal M.; Alkhateeb, Hassan B.; Al-Kali, Aref
Outcomes of Post-Transplant Rh-GCSF and Decitabine Maintenance Therapy in Patients With High-Risk Myeloid Neoplasm

移植后重组人粒细胞集落刺激因子和地西他滨维持治疗在高风险髓系肿瘤患者中的疗效

American Journal of Hematology
IF9.9
2025-07-290
OAAI
Mathias Palmer; Anmol Baranwal; Rami Basmaci; Khalil Hassan; Jade Kutzke; Gabriel Bartoo; Hemant Murthy; James Foran; Abhishek A. Mangaonkar; Mehrdad Hefazi; Aasiya Matin; William J. Hogan; Mark Litzow; Mithun Vinod Shah; Hassan B. Alkhateeb
Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status

TP53突变性骨髓增殖性肿瘤的结局异质性，基于疾病表型和突变状态

BRITISH JOURNAL OF HAEMATOLOGY
IF3.8
2025-05-220
PRE
Talha Badar; James M. Foran; Jan Philipp Bewersdorf; Yu-Hung Wang; Alexander Coltoff; Mobachir El Kettani; Kashish Shah; Francyess Denis Oliva; Chenyu Lin; Omer Jamy; Kendall Diebold; Rory M. Shallis; Alexa Siddon; Daniil Katkov; Alexa Schoen; Irum Khan; Charles E. Foucar; Ehab Atallah; Aaron D. Goldberg; Anand A. Patel
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

新诊断急性髓系白血病60岁及以上患者的分子特征分析：Beat AML临床试验报告

BLOOD CANCER JOURNAL
IF11.6
2025-04-030
OA
Hoff, Fieke W.; Huang, Ying; Welkie, Rina Li; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Patel, Prapti A.; Collins Jr, Robert H.; Baer, Maria R.; Duong, Vu H.; Blum, William G.; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca L.; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G.; Rosenberg, Leonard; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Yocum, Ashley O.; Borate, Uma M.; Mims, Alice S.; Byrd, John C.; Madanat, Yazan F.

研究方向

暂未获取到该数据
M
Mark R. Litzow
H 指数:106论文数:1,324被引数:4.7万
A
Aref Al‐Kali
H 指数:42论文数:586被引数:7,052
M
Mrinal M. Patnaik
H 指数:72论文数:1,243被引数:1.9万
H
Hassan B. Alkhateeb
H 指数:26论文数:426被引数:2,553
N
Naseema Gangat
H 指数:64论文数:779被引数:2.0万
A
Ayalew Tefferi
H 指数:152论文数:2,062被引数:10.2万
A
Abhishek A. Mangaonkar
H 指数:30论文数:394被引数:3,355
T
Talha Badar
H 指数:24论文数:329被引数:2,190
M
Mithun Vinod Shah
H 指数:35论文数:450被引数:4,545
K
Kebede H. Begna
H 指数:37论文数:323被引数:6,735